نتایج جستجو برای: pterocarya fraxinifolia lam spach

تعداد نتایج: 7348  

2014
Chenggang Li Po-Shun Lee Yang Sun Xiaoxiao Gu Erik Zhang Yanan Guo Chin-Lee Wu Neil Auricchio Carmen Priolo Jing Li Alfredo Csibi Andrey Parkhitko Tasha Morrison Anna Planaguma Shamsah Kazani Elliot Israel Kai-Feng Xu Elizabeth Petri Henske John Blenis Bruce D. Levy David Kwiatkowski Jane J. Yu

Lymphangioleiomyomatosis (LAM) is a progressive neoplastic disorder that leads to lung destruction and respiratory failure primarily in women. LAM is typically caused by tuberous sclerosis complex 2 (TSC2) mutations resulting in mTORC1 activation in proliferative smooth muscle-like cells in the lung. The female predominance of LAM suggests that estradiol contributes to disease development. Meta...

2015
Leslie Chávez-Galán Ranferi Ocaña-Guzmán Luis Torre-Bouscoulet Carolina García-de-Alba Isabel Sada-Ovalle

Lipoarabinomannan (LAM) is a lipid virulence factor secreted by Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis. LAM can be measured in the urine or serum of tuberculosis patients (TB-patients). Circulating monocytes are the precursor cells of alveolar macrophages and might be exposed to LAM in patients with active TB. We speculated that exposing monocytes to LAM could pro...

Journal: :Journal of acquired immune deficiency syndromes 2009
Maunank Shah Ebrahim Variava Charles B Holmes Alison Coppin Jonathan E Golub Jeremy McCallum Michelle Wong Binu Luke Desmond J Martin Richard E Chaisson Susan E Dorman Neil A Martinson

BACKGROUND Effective tuberculosis (TB) control in HIV-prevalent settings is hindered by absence of accurate, rapid TB diagnostic tests. We evaluated the accuracy of a urine lipoarabinomannan (LAM) test for TB diagnosis in South Africa. METHODS Hospitalized adults with signs and/or symptoms of active TB were enrolled. Sputum smear microscopy and mycobacterial culture, mycobacterial blood cultu...

Journal: :Journal of medical genetics 2000
A Astrinidis L Khare T Carsillo T Smolarek K S Au H Northrup E P Henske

Pulmonary lymphangioleiomyomatosis (LAM) is a rare disorder limited almost exclusively to women of reproductive age. LAM affects about 5% of women with tuberous sclerosis complex (TSC). LAM also occurs in women who do not have TSC (sporadic LAM). TSC is a tumour suppressor gene syndrome characterised by seizures, mental retardation, and tumours in the brain, heart, and kidney. Angiomyolipomas, ...

Journal: :Contraception 1997
M H Labbok V Hight-Laukaran A E Peterson V Fletcher H von Hertzen P F Van Look

A multicenter study of the Lactational Amenorrhea Method (LAM) was carried out to test the acceptability and efficacy of the method. Additionally, the data are used to test new constructs for improvement of method criteria. A protocol was designed at the Institute for Reproductive Health (IRH), Department of Obstetrics and Gynecology, Georgetown University Medical Center, a World Health Organiz...

2014
Alexey Tyryshkin Abhisek Bhattacharya Tony Eissa

Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease affecting some women with tuberous sclerosis complex (TSC). Sporadic LAM can develop in women without TSC, owing to somatic mutations in the TSC2 gene. Accumulating evidence supports the view of LAM as a low-grade, destructive, metastasizing neoplasm. The mechanisms underlying the metastatic capability of LAM cells remain poorl...

Journal: :Antiviral therapy 2012
Chien-Hung Chen Jing-Houng Wang Sheng-Nan Lu Tsung-Hui Hu Chao-Hung Hung Min-Hui Chang Chi-Sin Changchien Chuan-Mo Lee

BACKGROUND Here, we investigated the treatment response and evolution of HBV resistance during lamivudine (LAM) plus adefovir (ADV) and entecavir (ETV) monotherapy in patients with ADV-resistant mutants. METHODS Of the 53 patients with ADV-resistant mutants, 25 received combined LAM plus ADV therapy (LAM+ADV group) and 28 received ETV monotherapy (ETV group) for at least 12 months (median 24 ...

Journal: :Hepatobiliary surgery and nutrition 2013
Yaxiong Zhang Shiyang Kang Wenfeng Fang Xuan Wu Wenhua Liang

BACKGROUND Previous meta-analyses of non-randomized studies suggested that the hepatitis B immunoglobulin (HBIG) and lamivudine (LAM) combination therapy was significantly better than HBIG or LAM alone in preventing hepatitis B virus (HBV) recurrence after transplantation. However, substantial evidences supporting the superiority of combination therapy are still insufficient. Therefore, we soug...

2016
Jian-Hong Zhong Yang Ke Shao-Liang Zhu Lin Wang Cheng-Piao Luo Wen-Feng Gong Xue-Mei You Liang Ma Bang-De Xiang Le-Qun Li

AIM Lamivudine (LAM) and adefovir dipivoxil (ADV) are widely used in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), but few studies have directly compared their therapeutic efficacy and treatment cost. This study aims to compare LAM with ADV head-to-head in these patients. METHODS We retrospectively analyzed 201 patients with HBV-related HCC who underwent radica...

Journal: :PloS one 2016
Amira Alkharusi Elena Lesma Silvia Ancona Eloisa Chiaramonte Thomas Nyström Alfredo Gorio Gunnar Norstedt

Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease caused by mutations in the tumor suppressor genes encoding Tuberous Sclerosis Complex (TSC) 1 and TSC2. The protein product of the TSC2 gene is a well-known suppressor of the mTOR pathway. Emerging evidence suggests that the pituitary hormone prolactin (Prl) has both endocrine and paracrine modes of action. Here, we have investigat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید